CREST syndrome stands for
calcinosis, Raynaud's syndrome, esophageal dysmotility,
sclerodactyly and teleangiectasia. It is a special form of acral
scleroderma, a limited cutaneous manifestation of systemic
scleroderma. It is a chronic disease of the connective tissue that
begins with an inflammatory phase and is followed by a fibrotic
phase. The CREST syndrome is associated with the production of
antinuclear antibodies against centromeres. In the treatment of
this syndrome, prevention of cold, vasodilators and histamine
H2 antagonists or proton-pump inhibitors are used. We
present the case of a middle-aged woman with typical skin lesions
in predilection sites and positive laboratory findings...